S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
NASDAQ:OLMA

Olema Pharmaceuticals News Headlines

$5.74
-0.18 (-3.04%)
(As of 01/27/2022 04:00 PM ET)
Add
Compare
Today's Range
$5.59
$6.06
50-Day Range
$5.74
$22.76
52-Week Range
$5.59
$54.88
Volume
385,223 shs
Average Volume
440,435 shs
Market Capitalization
$231.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.98
Get Olema Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for OLMA and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Olema Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OLMA
News Sentiment

0.53

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OLMA Articles
This Week

3

0

OLMA Articles
Average Week



Olema Pharmaceuticals (NASDAQ:OLMA) News Headlines Today

SourceHeadline
MarketBeat logoOlema Pharmaceuticals, Inc. (NASDAQ:OLMA) Expected to Announce Earnings of -$0.51 Per Share
americanbankingnews.com - January 24 at 4:24 AM
nasdaq.com logoOlema Pharmaceuticals Inc Shares Fall 0.6% Below Previous 52-Week Low - Market Mover
nasdaq.com - January 14 at 1:31 AM
insidertrades.com logoKinney Horn Sells 5,251 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock
insidertrades.com - January 11 at 9:28 PM
finance.yahoo.com logoOlema Oncology to Present at 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 11:25 AM
finance.yahoo.com logoOlema Oncology to Present at 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 11:25 AM
finance.yahoo.com logoHas Olema Stock Hit Bottom? JPMorgan Sees a Silver Lining
finance.yahoo.com - December 1 at 7:37 PM
markets.businessinsider.com logoAfter Denying Data Leak, Olema Shares First Data For Lead Program In Breast Cancer Patients
markets.businessinsider.com - November 30 at 12:58 PM
investorplace.com logoOLMA Stock: The Breast Cancer Therapy News That Has Olema Pharmaceuticals Plunging Today
investorplace.com - November 30 at 12:01 PM
finance.yahoo.com logoOlema Oncology Announces First Clinical Data on OP-1250 in Advanced ER+ / HER2- Breast Cancer
finance.yahoo.com - November 30 at 7:58 AM
finance.yahoo.com logoOlema Oncology Announces First Clinical Data on OP-1250 in Advanced ER+ / HER2- Breast Cancer
finance.yahoo.com - November 30 at 7:58 AM
finance.yahoo.com logoOlema Oncology Issues Statement Regarding Falsified Information Circulating on Social Media
finance.yahoo.com - November 29 at 8:12 PM
finance.yahoo.com logoOlema Oncology to Present New Data on OP-1250 at 2021 San Antonio Breast Cancer Symposium
finance.yahoo.com - November 22 at 7:43 AM
finance.yahoo.com logoOlema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - November 10 at 7:42 PM
finance.yahoo.com logoOlema Oncology to Present at Two Upcoming Investor Conferences
finance.yahoo.com - November 9 at 9:07 AM
nasdaq.com logoOlema Pharmaceuticals (NASDAQ:OLMA) Is In A Good Position To Deliver On Growth Plans
nasdaq.com - October 27 at 11:24 AM
finance.yahoo.com logoNotable Olema Pharmaceuticals Insider Trades $175K In Company Stock
finance.yahoo.com - October 18 at 4:04 PM
benzinga.com logoChief Business Officer Of Olema Pharmaceuticals Trades $155K In Company Stock
benzinga.com - October 13 at 1:25 PM
finance.yahoo.com logoOlema Oncology Announces Trials in Progress Poster on OP-1250 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
finance.yahoo.com - September 30 at 9:57 PM
finance.yahoo.com logoOlema Oncology to Present Data on OP-1250 at the 2021 JCA-AACR Precision Cancer Medicine International Conference
finance.yahoo.com - September 9 at 7:40 AM
finance.yahoo.com logoOlema Oncology to Present at Morgan Stanley 19th Annual Global Healthcare Conference
finance.yahoo.com - August 30 at 8:47 PM
finance.yahoo.com logoCompanies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth
finance.yahoo.com - August 18 at 3:48 PM
finance.yahoo.com logoOlema Oncology Reports Second Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - August 10 at 9:08 PM
finance.yahoo.com logoOlema Oncology to Present at Canaccord Genuity 41st Annual Growth Conference
finance.yahoo.com - July 28 at 7:03 PM
markets.businessinsider.com logoOlema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference
markets.businessinsider.com - May 18 at 6:04 PM
finance.yahoo.com logoOlema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference
finance.yahoo.com - May 18 at 6:04 PM
finance.yahoo.com logoOlema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - May 11 at 5:43 PM
finance.yahoo.com logoOlema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
finance.yahoo.com - April 7 at 7:45 AM
finance.yahoo.com logoOlema Oncology Appoints Oncology Biotech Executive Yi Larson, MBA, to Board of Directors
finance.yahoo.com - April 6 at 8:43 AM
finance.yahoo.com logoOlema Oncology Appoints Oncology Biotech Executive Yi Larson, MBA, to Board of Directors
finance.yahoo.com - April 6 at 8:43 AM
finance.yahoo.com logoOlema Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates
finance.yahoo.com - March 17 at 6:42 PM
marketwatch.com logoLondon-Gates Senior Member Believes These Biotech Stocks Are a Must Buy
marketwatch.com - March 12 at 4:05 PM
finance.yahoo.com logoOlema Oncology Announces Late-Breaking Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021
finance.yahoo.com - March 10 at 8:01 PM
finance.yahoo.com logoOlema Oncology to Participate at Upcoming Virtual Investor Conferences
finance.yahoo.com - February 23 at 8:39 AM
finance.yahoo.com logoWe're Hopeful That Olema Pharmaceuticals (NASDAQ:OLMA) Will Use Its Cash Wisely
finance.yahoo.com - February 19 at 1:30 PM
msn.com logoHarry Domash, Online Investing | Steal stock ideas from four hot funds
msn.com - January 14 at 6:14 PM
finance.yahoo.com logoOlema Oncology to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference
finance.yahoo.com - December 17 at 9:36 AM
barrons.com logoOlema Pharmaceuticals Inc.
barrons.com - December 15 at 11:29 PM
finance.yahoo.com logoOlema Oncology Announces Two Poster Presentations at the San Antonio Breast Cancer Symposium 2020
finance.yahoo.com - December 7 at 10:14 AM
ca.finance.yahoo.com logoOlema Pharmaceuticals, Inc. (OLMA)
ca.finance.yahoo.com - December 4 at 11:31 PM
finance.yahoo.com logoKinnate Biopharma Stock Nearly Doubles in Debut. More Deals Are Coming.
finance.yahoo.com - December 3 at 9:09 PM
finance.yahoo.com logoKinnate Biopharma IPO Soars 115%. More Deals Are Coming.
finance.yahoo.com - December 3 at 4:08 PM
benzinga.com logoOlema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
benzinga.com - November 25 at 1:19 PM
marketwatch.com logoLast Week’s IPO Recap
marketwatch.com - November 25 at 12:34 AM
nasdaq.com logoTuesday 11/24 Insider Buying Report: OLMA, COTY
nasdaq.com - November 25 at 12:34 AM
finance.yahoo.com logoMaravai LifeSciences Jumps Nearly 19% in IPO, While Sotera Pops 17%
finance.yahoo.com - November 25 at 12:34 AM
finance.yahoo.com logoOlema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - November 25 at 12:34 AM
Get Olema Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for OLMA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.